The Definition of Primary and Secondary Glioblastoma
Определение первичной и вторичной глиобластомы
2012-12-04
SCID: 54.1/ytnpm5z3
Discuss with AI
IDH1 mutationsdiffuse astrocytomahypermethylation phenotypeprimary glioblastomasecondary glioblastoma
Figures from the paper
Abstract (AI)
Glioblastoma is the most frequent and malignant brain tumor. The vast majority of glioblastomas (~90%) develop rapidly de novo in elderly patients, without clinical or histologic evidence of a less malignant precursor lesion (primary glioblastomas). Secondary glioblastomas progress from low-grade diffuse astrocytoma or anaplastic astrocytoma. They manifest in younger patients, have a lesser degree of necrosis, are preferentially located in the frontal lobe, and carry a significantly better prognosis. Histologically, primary and secondary glioblastomas are largely indistinguishable, but they differ in their genetic and epigenetic profiles. Decisive genetic signposts of secondary glioblastoma are IDH1 mutations, which are absent in primary glioblastomas and which are associated with a hypermethylation phenotype. IDH1 mutations are the earliest detectable genetic alteration in precursor low-grade diffuse astrocytomas and in oligodendrogliomas, indicating that these tumors are derived from neural precursor cells that differ from those of primary glioblastomas. In this review, we summarize epidemiologic, clinical, histopathologic, genetic, and expression features of primary and secondary glioblastomas and the biologic consequences of IDH1 mutations. We conclude that this genetic alteration is a definitive diagnostic molecular marker of secondary glioblastomas and more reliable and objective than clinical criteria. Despite a similar histologic appearance, primary and secondary glioblastomas are distinct tumor entities that originate from different precursor cells and may require different therapeutic approaches.
Key Findings
1
Approximately 90% of glioblastomas arise de novo in elderly patients as primary glioblastomas, without detectable precursor lesions.
2
IDH1 mutations, absent from primary glioblastomas and associated with a hypermethylation phenotype, are decisive molecular markers of secondary glioblastoma.
3
Primary and secondary glioblastomas are histologically similar but differ substantially in genetic and epigenetic profiles.
4
Primary and secondary glioblastomas originate from different neural precursor cells and may require distinct therapeutic approaches; IDH1 status is more reliable diagnostically than clinical criteria.
5
Secondary glioblastomas progress from lower-grade astrocytomas, occur in younger patients, show less necrosis and preferential frontal-lobe localization, and have better prognosis.
Research Object
Primary and secondary glioblastomas
Research Subject
Their distinguishing epidemiologic, clinical, histopathologic, genetic, epigenetic, and expression features, including the diagnostic significance and biologic consequences of IDH1 mutations
Publication Details
Publication Date
2012-12-04
Journal
Publisher
ISSN
Cited by
1216
Access Type
Author Information
Download PDF
Subscribe to digest